search
Back to results

Effect of Ciclesonide on Exercise Induced Bronchoconstriction

Primary Purpose

Asthma

Status
Completed
Phase
Phase 3
Locations
Canada
Study Type
Interventional
Intervention
ciclesonide
ciclesonide
Sponsored by
Hamilton Health Sciences Corporation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Asthma focused on measuring asthma, exercise induced bronchoconstriction, sputum eosinophils

Eligibility Criteria

12 Years - 30 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • stable asthma not on maintenance asthma medications
  • exercise induced bronchoconstriction on dry air exercise challenge.

Exclusion Criteria:

  • other significant co-morbidity or treatments that might interfere with the conduct or results of the study
  • fail to return to baseline after a maximum washout period of 8 weeks
  • unable to perform the procedures of the study

Sites / Locations

  • McMaster University Medical Centre

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

1

2

Arm Description

ciclesonide 50 and 200ug

ciclesonide 100ug and 400ug

Outcomes

Primary Outcome Measures

change in maximum fall in FEV1 induced by dry air exercise challenge after treatment compared to the respective pretreatment value

Secondary Outcome Measures

Changes in sputum cell counts,bronchial responsiveness to mannitol and other clinical parameters of asthma control after treatment compared to respective pre-treatment value.

Full Information

First Posted
September 4, 2007
Last Updated
October 20, 2009
Sponsor
Hamilton Health Sciences Corporation
Collaborators
Kolding Sygehus, Takeda
search

1. Study Identification

Unique Protocol Identification Number
NCT00525772
Brief Title
Effect of Ciclesonide on Exercise Induced Bronchoconstriction
Official Title
Effect of Ciclesonide on Exercise Induced Bronchoconstriction
Study Type
Interventional

2. Study Status

Record Verification Date
October 2009
Overall Recruitment Status
Completed
Study Start Date
November 2001 (undefined)
Primary Completion Date
November 2007 (Actual)
Study Completion Date
November 2007 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Hamilton Health Sciences Corporation
Collaborators
Kolding Sygehus, Takeda

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to study the effects of once daily inhaled ciclesonide at varying doses on exercise provoked asthma symptoms, fall in lung function after exercise and sputum characteristics.
Detailed Description
To study the effects of 4 doses of ciclesonide on exercise-induced bronchoconstriction, bronchial responsiveness to mannitol, sputum parameters and other parameters of asthma control in asthmatic patients. The primary aim was to evaluate exercise-induced bronchoconstriction as a method of determining the dose and time responses of inhaled corticosteroid therapy. The secondary aims were to evaluate the dose and time responses of sputum parameters and responsiveness to mannitol to inhaled corticosteroid therapy. Furthermore to explore the relationship(s) between exercise induced bronchoconstriction, sputum parameters and mannitol responsiveness.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthma
Keywords
asthma, exercise induced bronchoconstriction, sputum eosinophils

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
26 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Active Comparator
Arm Description
ciclesonide 50 and 200ug
Arm Title
2
Arm Type
Active Comparator
Arm Description
ciclesonide 100ug and 400ug
Intervention Type
Drug
Intervention Name(s)
ciclesonide
Other Intervention Name(s)
ciclesonide (Alvesco)
Intervention Description
low dose- 50ug and 200ug
Intervention Type
Drug
Intervention Name(s)
ciclesonide
Other Intervention Name(s)
ciclesonide (Alvesco)
Intervention Description
high dose- 100ug and 400ug
Primary Outcome Measure Information:
Title
change in maximum fall in FEV1 induced by dry air exercise challenge after treatment compared to the respective pretreatment value
Time Frame
at 1 week of treatment
Secondary Outcome Measure Information:
Title
Changes in sputum cell counts,bronchial responsiveness to mannitol and other clinical parameters of asthma control after treatment compared to respective pre-treatment value.
Time Frame
after 1, 2, 3, weeks of treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
12 Years
Maximum Age & Unit of Time
30 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: stable asthma not on maintenance asthma medications exercise induced bronchoconstriction on dry air exercise challenge. Exclusion Criteria: other significant co-morbidity or treatments that might interfere with the conduct or results of the study fail to return to baseline after a maximum washout period of 8 weeks unable to perform the procedures of the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paul O'Byrne, MD
Organizational Affiliation
McMaster University
Official's Role
Principal Investigator
Facility Information:
Facility Name
McMaster University Medical Centre
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L8N 3Z5
Country
Canada

12. IPD Sharing Statement

Citations:
PubMed Identifier
16675326
Citation
Subbarao P, Duong M, Adelroth E, Otis J, Obminski G, Inman M, Pedersen S, O'byrne PM. Effect of ciclesonide dose and duration of therapy on exercise-induced bronchoconstriction in patients with asthma. J Allergy Clin Immunol. 2006 May;117(5):1008-13. doi: 10.1016/j.jaci.2005.11.048.
Results Reference
background
PubMed Identifier
18071011
Citation
Duong M, Subbarao P, Adelroth E, Obminski G, Strinich T, Inman M, Pedersen S, O'Byrne PM. Sputum eosinophils and the response of exercise-induced bronchoconstriction to corticosteroid in asthma. Chest. 2008 Feb;133(2):404-11. doi: 10.1378/chest.07-2048. Epub 2007 Dec 10.
Results Reference
derived

Learn more about this trial

Effect of Ciclesonide on Exercise Induced Bronchoconstriction

We'll reach out to this number within 24 hrs